 | Revance Therapeutics, Inc. | |||
| NGM : RVNC || Location: United States | ||||
$3.29-0.28 (-7.84%) |
2.64 M | 3.23 - 3.5 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 11.625 M |
| March 28, 2024 | 13.551 M |
| March 15, 2024 | 10.866 M |
| Feb. 29, 2024 | 11.879 M |
| Feb. 15, 2024 | 12.340 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.74 | -0.62 | 16.06% |
| 09/30/2023 | -0.87 | -1.63 | -87.33% |
| 06/30/2023 | -0.79 | -0.80 | -0.84% |
| 03/31/2023 | -0.71 | -0.74 | -3.83% |
| 12/31/2022 | -0.97 | -0.95 | 1.86% |
RVNC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 104.216M | Shares Float | 70.709M |
| Short Float | 11.625M | Market Cap | 372.05M |
| Institution ownership | 76.20% | Insider ownership | 8.473% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.83 | Forward EPS | -1.06 |